Cancer care disparities in Kentucky
Kentucky leads the nation in cases of lung cancer. Cancer patients in our region also experience barriers to care and racial disparities in care. In a recent presentation on pursuing health equity in lung cancer […]
View more
Updates in screening and treatment of leading gastrointestinal cancers
Gastrointestinal cancers can occur anywhere from the esophagus to the anus and in attached structures such as the pancreas and liver. They include the second- and third-deadliest cancers in the United States. Not counting skin [...]
View more
Douglas A. Nelson, M.D., joins Norton Cancer Institute
Douglas A. Nelson, M.D., has joined Norton Cancer Institute, practicing at the downtown Louisville and St. Matthews offices. Dr. Nelson most recently was an associate professor in the Department of Gastrointestinal Medical Oncology and Department [...]
View more
Clinical trial summary: Venetoclax plus LDAC for adult AML patients at high risk of toxicity
Clinical challenge Acute myeloid leukemia (AML) patients ages 75 and older, and younger adults with comorbidities, are often ineligible to receive standard intensive chemotherapy due to high rates of toxicity and early mortality. As a [...]
View more
Cancer care for the whole person includes emotional health
No one needs to face cancer alone. A cancer diagnosis is life-altering, and living with cancer can cause feelings of fear, sadness, nervousness and uncertainty, and a sense of being overwhelmed. At Norton Cancer Institute, […]
View more
Narrowing racial and ethnic disparities among lung cancer patients
Black Americans have the highest death rate and shortest survival rate of any racial or ethnic group in the U.S. for most cancers, according to a 2019 study. Lung cancer is the second most common [...]
View more
Stereotactic ablative radiation therapy (SABR) for oligometastatic disease
Stereotactic ablative radiation therapy (SABR) is playing an important role in treating oligometastatic patients with breast, lung, colorectal and prostate tumors, according to a review of published literature. With each of these cancers, SABR showed […]
View more
Basel Altoos, M.D., joins Norton Cancer Institute
Basel M. Altoos, M.D., a board-certified radiation oncologist, has joined Norton Cancer Institute and will see patients downtown and at King’s Daughters’ Health in Madison, Indiana. Refer a patient To refer a patient to Norton [...]
View more
Drug targeting prostate cancer cells to deliver radioisotope prolongs survival in trial
A cutting-edge new treatment specifically targets prostate cancer cells to deliver a tumor-killing radioisotope and helped extend patients’ lives longer in an international clinical trial (VISION Study), according to a study published in the New […]
View more
Patient benefits of the Norton Cancer Institute’s multidisciplinary clinics
At Norton Cancer Institute, our goal is to have newly diagnosed cancer patients meet all the potential providers who could be part of their care. With that in mind — and more — we’ve established multidisciplinary […]
View more
HPV and your lesbian patients
Lesbians may be at higher risk for HPV because of historical health care barriers that may have caused reluctance to get preventive screenings. Making matters worse, much of the discussion around sexually transmitted infections (STIs) […]
View more
Screening for lung, colon and breast cancers take priority
After many put off their preventive cancer screenings, Norton Cancer Institute is working to screen as many people as possible as early as possible for lung, colon and breast cancers. Adding urgency to the effort, […]
View more